News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
Clinical - Discontinued
Takeda Pharmaceutical Co. Ltd. (TKPYY) Terminates Development Of Top Prostate Cancer Prospect Orteronel 6/20/2014
Johnson & Johnson (JNJ) Halts Development Of Botox Rival, Axes Staffers 4/15/2014
Forest Laboratories, Inc. (FRX) To Discontinue NAMENDA® Tablets, Focus On Once-Daily NAMENDA XR® 2/17/2014
Sanofi (France) (SAN.PA) Suffers Another Setback, Ditches Late-Stage Bone Marrow Cancer Drug 11/19/2013
ImmunoGen, Inc. (IMGN) Discontinues Study as Lung Cancer Drug Flops; Stock Crashes -18.97%% at Market Close (November 5, 2013) 11/6/2013
Imprimis Pharmaceuticals (immy) to Shift Focus, Discontinues Impracor Phase 3 Program to Focus on Other Areas 11/6/2013
Ariad Pharmaceuticals, Inc. (ARIA) Discontinues Phase 3 Study of Cancer Drug Iclusig; Shares Decimated, Falls -40.67% at Market Close (October 18, 2013) 10/22/2013
Medivir AB (MVIRb.F), Daewoong Pharmaceutical Co., Ltd. Discontinue Hepatitis B Drug Development 9/6/2013
Medivir AB (MVIRb.F) Makes Strategic Decision to Discontinue its NS5A Inhibitor Program 8/15/2013
Albany Molecular Research, Inc. (AMRI) (AMRI): Bristol-Myers Squibb Company (BMY) Stops Development of Depression Drug 8/14/2013
Isis Pharmaceuticals, Inc. (ISIS) Ditches Rheumatoid Arthritis Drug After Phase 2 Trial Disappoints 8/6/2013
Higher Death Rates Force Celgene Corporation (CELG) to End Blood Cancer Trial 7/22/2013
Roche (RHHBY) Halts Diabetes Drug Trial in Blow to Pipeline 7/12/2013
Roche (RHHBY) Backs Out on Seaside Therapeutics Drug Trial for Fragile X. Parents Dismayed 6/11/2013
Sanofi (France) (SAN.PA) Pulls the Plug on Two Late-Stage Drugs, Plans $285 Million Charge 6/4/2013
Pfizer Inc. (PFE) Halts Study of Non-Hodgkin's Lymphoma Drug 5/29/2013
Merck & Co., Inc. (MRK) Drops Development of Parkinson's Drug 5/28/2013
Eli Lilly and Company (LLY) to Take $30 Million Charge After Cancer Drug Fails Phase 3 Trial 5/15/2013
CytRx Corporation (CYTR) Ditches Lung Cancer Drug After Phase 2 Trial Failure 5/10/2013
Bayer AG (BAY.F) Halts Study of Hemophilia Therapy BAY 86-6150 Due to Safety Concerns 5/7/2013
Celltrion, Inc. Drops Late-Stage Trial of Roche (RHHBY) Rituxan Drug Copy 4/19/2013
Liver Toxicity Brings Melanoma Study on Bristol-Myers Squibb Company (BMY)/Roche (RHHBY) Drugs to a Halt 4/4/2013
Clavis Pharma ASA Stops Elacytarabine Development on Negative Ph3 Trial in AML 4/3/2013
ZIOPHARM Oncology, Inc. (ZIOP.OB) Cancer Drug Fails in Late-Stage Trial; Shares Plunge 3/27/2013
BioLineRx Ltd. Says CLARITY Trial of BL-1020 Did Not Meet Primary Efficacy Endpoint, to Discontinue Study 3/21/2013
Pfizer Inc. (PFE) Halts Development of Hepatitis C Drug 3/19/2013
Moberg Derma Discontinues Clinical Development of Limtop 3/11/2013
AEterna Zentaris (AEZS) to Discontinue Phase 3 Trial in Multiple Myeloma With Perifosine 3/11/2013
FDA Halts Amgen (AMGN) Trial After Teen Death 3/4/2013
Amgen (AMGN), UCB, Inc. (UCBJF.PK) Halt Testing of Fracture-Healing Drug 2/13/2013
Eli Lilly and Company (LLY) to Cease Tabalumab Phase 3 RA Program 2/8/2013
Idenix Pharmaceuticals, Inc. (IDIX) Halts Development of Two Hepatitis C Treatments 2/6/2013
Vanda Pharmaceuticals, Inc. (VNDA) to Stop Developing Anti-Depressant 2/1/2013
What Merck & Co., Inc. (MRK) Told Doctors About Tredaptive Before It Stopped Selling It 1/15/2013
Merck & Co., Inc. (MRK) Pulls Tredaptive Cholesterol Pill After a Flop 1/14/2013
Tranzyme Pharma (TZYM) Stops Mid-Stage Gastric Study After Drug Fails 12/18/2012
Boehringer Ingelheim Corporation Ends Phase 2 Trial of Dabigatran in Mechanical Valve Patients 12/13/2012
Geron Corporation (GERN) Ends Brain Cancer Drug Study, Cuts 43 Jobs 12/10/2012
Bristol-Myers Squibb Company (BMY) Drops Alzheimer's Drug on Little Benefit 12/5/2012
Ranbaxy Laboratories (RANBAXY.BO) Halts Production of Generic Lipitor 12/3/2012
Merck & Co., Inc. (MRK) Shelves Development of Another Diabetes-Cholesterol Program 11/14/2012
Roche (RHHBY)'s Good Cholesterol Drug Shows Negative Side Effects 11/7/2012
Bioniche Life Sciences Inc. (BNC) Discontinues Current Phase 3 Clinical Trial With Urocidin™ 11/5/2012
Ex-Geron Corporation (GERN) CEO Launches Effort to Revive Lost Stem Cell Program 10/29/2012
Abbott Laboratories (ABT), Reata Pharmaceuticals, Inc. Kidney Disease Drug Trial Stopped 10/22/2012
Novartis AG (NVS) Stops Developing Long-Acting Version of Vanda Pharmaceuticals, Inc. (VNDA)'s Fanapt 10/12/2012
Oxford BioMedica PLC (OXB.L) Abandons Prostate Cancer Vaccine Study 10/11/2012
Anacor Pharmaceuticals, Inc. Says GlaxoSmithKline (GSK) Stops Development of Antibiotic 10/8/2012
ArQule, Inc. (ARQL), Daiichi Sankyo, Inc. (4568.t) Discontinue Lung Cancer Drug Trial 10/3/2012
Novo Nordisk A/S (NVO) Halts Development of Hemophilia Drug 10/2/2012
Vertex Pharmaceuticals (MA) (VRTX) Ends Work on One Hepatitis C Drug, Continues Another 9/26/2012
Astex Pharmaceuticals (ASTX) Ends Development of Lung Cancer Drug 9/24/2012
Targacept, Inc. (TRGT) to Cut More Jobs, Halt ADHD Drug Development After Failed Phase 2 Trial 9/18/2012
Johnson & Johnson (JNJ) Ends Trial of Skin-Disorder Drug Over Adverse Events 9/17/2012
Lundbeck Inc. (LUN.CO) Halts Sales of Leukemia Drug Over Supply Problems 9/17/2012
Geron Corporation (GERN) Ends Breast Cancer Study of Imetelstat 9/11/2012
Zalicus Inc. (ZLCS) to Halt Further Clinical Development With Synavive 9/10/2012
Palatin Technologies (PTN) Says Partner AstraZeneca PLC (AZN) to Halt Further Development of Obesity Drug 9/10/2012
Eli Lilly and Company (LLY) Ends Development of Schizophrenia Drug 8/30/2012
Bristol-Myers Squibb Company (BMY) Ends Hepatitis C Development After Patient Death; Eats a $1.8 Billion Loss 8/27/2012
Gilead Sciences, Inc. (GILD) Stops Development of PAH Drug After Missing Study Goal 8/23/2012
Pfizer Inc. (PFE), Johnson & Johnson (JNJ) Scrap Alzheimer's Drug After Phase III Study Fails 8/8/2012
Infinity Pharmaceuticals Inc. (INFI) Pulls Plug on Cancer Drug Saridegib Trials 6/19/2012
BioInvent (BOVNF), ThromboGenics NV (TBGNF) Plunges as Development of Anticoagulent is Dropped 6/5/2012
Chelsea Therapeutics, Inc. (CHTP) Halts Development of Arthritis Drug 6/1/2012
Q-Med AB Discontinues the Breast Indication for Macrolane 4/17/2012
SciClone Pharmaceuticals, Inc. (SCLN) to Discontinue Development of SCV-07 Oral Mucositis Trial 3/7/2012
Karo Bio AB Axes Clinical Dyslipidemia Program After Side Effects Surface in Animal Study 2/15/2012
Theratechnologies Inc. (TH.TO) Cuts 60% of Workforce, Refocus for 2013 12/7/2011
Sanofi (France) (SASY.PA) Discontinues Selling Authorized Generic Version of Lovenox 12/5/2011
National Institutes of Health (NIH) Discontinues Tenofovir Vaginal Gel in 'Voice' HIV Prevention Study 11/29/2011
Celgene International Sárl (CELG) Will Discontinue Phase III MAINSAIL(R) Trial in Castrate-Resistant Prostate Cancer 11/28/2011
Moberg Derma Discontinues Preclinical Development Program for A-Fizz 10/27/2011
Conatus Pharmaceuticals Inc.Terminates Phase 2 Clinical Trial of CTS-1027 10/27/2011
Takeda Pharmaceutical Co. Ltd. (TKDG.DE) Drops Europe Development of Insomnia Drug 10/10/2011
Sangamo BioSciences, Inc. (SGMO) Shares Plunge on Diabetic Neuropathy Drug Failure, to Terminate Development 10/4/2011
Astellas Pharma Inc. (YPH.BE) Halts Development of Anti-Clotting Drug 9/29/2011
FDA Issues Clinical Hold on Cancer Drug by Immunomedics, Inc. (IMMU) 9/26/2011
Eisai Inc. (ESALF.PK) Discontinues Global Development of Rabeprazole Sodium Extended-Release Capsules, 50 mg 9/6/2011
Shire plc Falls After Scrapping Dermagraft as Leg Ulcer Therapy 8/25/2011
Endo Pharmaceuticals (ENDP) Terminates Pain Program After Failed Trial; Ends Pact With Grunenthal GmbH 8/19/2011
Amylin Pharmaceuticals, Inc. (AMLN), Takeda Pharmaceutical Co. Ltd. (TKDG.DE) Halt Obesity Drug Development Following Commercial Reassessment of the Program 8/8/2011
Merck & Co., Inc. (MRK) to Cut Up to 13,000 Jobs, Q2 Profit Rises; Discontinues Ph3 Migraine Program 8/4/2011
BeiLu Pharma Gives Up on Melatonin-based Depression Drug 7/19/2011
Lack of Partner Prompts Genmab A/S (GEN.CO) to Drop Zalutumumab 6/28/2011
Diamyd Medical AB Discontinues US Phase III Trial with Type I Diabetes Product 6/24/2011
Enzon Pharmaceuticals, Inc. (ENZN) Ditches PEG-SN38 for mCRC but Continues Development in Other Cancers 5/19/2011
Drugmakers Including Johnson & Johnson (JNJ) and Procter & Gamble (PG) Eliminate Infant Drops of Key Medicine 5/5/2011
Pfizer Inc. (PFE) Stops Making Canine Tick Med Over Side Effects 4/25/2011
Galapagos NV (GLPG.BR) Discontinues Phase II Trial for GLPG0259, Focuses Resources on Other Rheumatoid Arthritis Programs 4/15/2011
StemCells Inc. (STEM) Discontinues Batten Disease Program 4/8/2011
AstraZeneca PLC (AZN) Pulls Bloodthinner In France 3/24/2011
AstraZeneca PLC (AZN) Pulls Asthma Product, Hitting SkyePharma Inc. (SKYE) 3/7/2011
Innate Pharma Drops IPH 1101 Development 3/4/2011
Pfizer Inc. (PFE) Drops 15 Pipeline Projects 3/1/2011
Sanofi-Aventis (France) (SASY.PA) to Withdraw Anzemet From Five Countries 2/15/2011
Idenix Pharmaceuticals, Inc. (IDIX) Cancels Hepatitis C Drug On Toxicity Worries; Shares Fall 2/10/2011
Hospira, Inc. (HSP) to Stop Making Drug Used in Executions 1/24/2011
Genentech (RHHBY) Informs Customers of Important Information About Triad Group's Alcohol Prep Pads 1/14/2011
More Evidence Links Roche (RHHBY)'s Avastin to Heart Failure in Breast Cancer Patients 1/6/2011
Ipsen Closes BIM 23A760 Phase II Trials For Acromegaly; Compound Does Not Meet Expectations 12/15/2010
Servier's Diabetes Drug, Mediator May Be Linked to 500 Deaths 11/16/2010
Transition Therapeutics Inc. (TTH.TO) and Eli Lilly and Company (LLY) Stops Diabetes Drug Development 9/17/2010
Basilea Pharmaceutica (BSLN.SW) Announces Discontinuation of Sale of Ceftobiprole by Janssen-Cilag AG, a Johnson & Johnson (JNJ) Company, In Switzerland 9/9/2010
Karo Bio AB Announces That Merck & Co., Inc. (MRK) Discontinues Development of Mk-6913 for Hot Flashes 9/8/2010
Shire Pharmaceuticals (SHPGY) to Pull Low Blood Pressure Drug from Market 8/18/2010
Teva Pharmaceutical Industries Limited (TEVA) Lays Off 70 as Propofol is Abandoned 8/16/2010
Pfizer Inc. (PFE) Pulls Leukemia Drug Mylotarg From U.S. Market After Deaths, No Proven Benefit 6/22/2010
Trubion Pharmaceuticals Inc. (TRBN) Says Pfizer Inc. (PFE) to Stop Development of Arthritis Drug, TRU-015 6/15/2010
Teva Pharmaceutical Industries Limited (TEVA) To Stop Manufacturing Propofol Sedative 5/28/2010
FDA Says Asthma and COPD Inhalers That Contain Ozone-depleting CFCs to be Phased Out; Alternative Treatments Available 4/14/2010
GenVec Inc. (GNVC) Says Cancer Drug Not Effective, Ends Trial 3/30/2010
Novelos Therapeutics, Inc. (NVLT) Discontinues Current Development Program for NOV-002 in NSCLC; Primary and Secondary Endpoints Not Met in Phase 3 Trial 3/18/2010
Pfizer Inc. (PFE) (JOBS) Drops 100 Drugs from Pipeline 1/29/2010
Pfizer Inc. (PFE) (JOBS) Ends Late-stage Lung-Cancer Study; Analysis Showed it Would Miss Main Goal 12/30/2009
Arena Pharmaceuticals, Inc. (ARNA) Announces Merck KGaA (MKGAF.PK) Discontinues Development of Investigational Niacin Receptor Agonist Program for Atherosclerosis 12/28/2009
Sanofi-Aventis (France) (SASY.PA) Stops Development of Two Drugs: Eplivanserin in Insomnia and Thrombosis Drug Idrabiotaparinux 12/21/2009
BioMS Medical (MS.TO) Provides Corporate Update; Company will Not Pursue Further Late Stage Clinical Trials with Dirucotide in MS 12/18/2009
Thallion Pharmaceuticals Inc. Discontinues Phase II Glioblastoma Multiforme Trial After Review of Interim Data 12/18/2009
Seattle Genetics, Inc. (SGEN) (JOBS) Stops Mid-Stage Cancer Trial 10/6/2009
SciClone Pharmaceuticals, Inc. (SCLN) (JOBS) Drops Cancer Drug Development 10/5/2009
ZymoGenetics, Inc. (ZGEN) (JOBS) Says Merck Serono Discontinues MS Trials 9/29/2009
Merck & Co., Inc. (MRK) (JOBS) Abandons One Migraine Drug MK-3207, Pursues Another 9/11/2009
Antisoma PLC (ASM.L) Announces Discontinuation of Development of AS1402 8/10/2009
Insmed Incorporated (INSM) Stops Supplying Iplex To New Patients 7/27/2009
Repros Therapeutics Inc. (RPRX) to Stop Using 50 mg Dose in Fibroids Study 7/1/2009
UCB Group (UCBJF.PK) and Biogen Idec, Inc. (Massachusetts) (BIIB) Discontinue Phase II Clinical Trial of CDP323 7/1/2009
Roche Holding AG (RHHBF.PK) Stops Selling Acne Drug Accutane 6/30/2009
ImmunoGen, Inc. (IMGN) to End Stomach-Cancer Drug Development 6/15/2009
Halozyme Therapeutics, Inc. (HALO) Not to Develop Osteoporosis Study Further 6/5/2009
Pfizer Inc. (PFE) (JOBS) Discontinues Late-stage Trial of Sunitinib in Advanced Breast Cancer 6/3/2009
Sanofi-Aventis (France) (SASY.PA) Stops 14 Candidate Drugs, Profit Up 15% 4/29/2009
Targacept, Inc. (TRGT) Provides Update on TC-6499 and Pain Program in GlaxoSmithKline (GSK) Alliance - Data Does Not Support Further Development 3/11/2009
Pfizer Inc. (PFE) Drops Development of 2 Late-Stage Drugs 2/24/2009
Enzon Pharmaceuticals, Inc. (ENZN) Discontinues Further Development of rhMBL 2/10/2009
Synvista Therapeutics Announces Termination of Clinical Trials of Alagebrium and SYI-2074 and Provides Business Update 1/29/2009
Akesis Pharmaceuticals Discontinues Sole Clinical Development Program and Announces Intent to File for Chapter 7 Bankruptcy 1/22/2009
Nile Therapeutics, Inc. Announces Focus on CD-NP for Acute Heart Failure and Termination of 2NTX-99 Program 1/20/2009
Neurobiological Technologies, Inc. (NTII) Ends Stroke Drug Development; Cuts Jobs 1/13/2009
EpiCept Corporation (EPCT) Discontinues Drug Discovery Operations and Reduces Workforce 1/12/2009
Avigen, Inc. (AVGN) Stops Development of Lead Drug; Reduces Headcount by 70% 12/22/2008
SkyePharma Inc. (SKYE) Ceases Commercialization of formoterol Certihaler(R) in the United States 12/19/2008
Adolor Corporation (ADLR) to Stop Development of Bowel Dysfunction Drug 12/18/2008
Solvay Pharmaceuticals, Inc. Ends Research on Cbesity Treatment Compound 11/17/2008
Pfizer Inc. (PFE) (JOBS) Ends Development of Obesity Drug 11/6/2008
Sanofi-Aventis (France) (SASY.PA) Ends Research on Troubled Diet Drug, Accomplia 11/6/2008
Mayo Clinic Cuts Clinical Trial Services Business; Jobs Affected 11/6/2008
ZymoGenetics, Inc. (ZGEN) Kidney Disease Drug Study Stopped 10/28/2008
Biogen Idec, Inc. (Massachusetts) (BIIB) (JOBS) To Discontinue Rheumatoid Arthritis Drug As Drug Fails To Meet Primary, Secondary Endpoints 10/10/2008
Genmab A/S (GNMSF.PK) Announces Discontinuation of Zanolimumab Program and Job Cuts 10/8/2008
Life Science Weekly inSite (Sep. 29 - Oct. 3) 10/6/2008
Merck & Co., Inc. (MRK) (JOBS) Discontinues Development of Investigational Medicine Taranabant for Obesity 10/2/2008
Most Failed Clinical Trials Are Never Published 9/23/2008
Valens Pharma Ltd. Announces Next Steps; Company Has Suspended Work on its DCA i.v Program 8/6/2008
EMD Serono, Inc. to Discontinue Geref Diagnostic 8/5/2008
Ambrilia Biopharma Inc. Provides Update on PPL-100; Merck & Co., Inc. (MRK) (JOBS) Places Development Hold on Drug 7/28/2008
Progen Pharmaceuticals Limited (PGLA) Terminates PATHWAY Trial & Confirms Focus on Potential High Value Molecules and M&A 7/24/2008
MethylGene and Celgene (CELG) Announce Precautionary Suspension of New Enrollments Into MGCD0103 Clinical Trials 7/23/2008
National Institute of Allergy And Infectious Diseases (NIAID) Will Not Move Forward with the PAVE 100 HIV Vaccine Trial 7/18/2008
Jury Finds Johnson & Johnson (JNJ) (JOBS) Not Liable in Motrin Lawsuit 7/18/2008
DUSA Pharmaceuticals (DUSA) Announces Update on Nicomide(R); Company Places Voluntary Hold on Existing Inventory 7/18/2008
Infinity Pharmaceuticals, Inc. Discontinues Phase 2 Signal-Finding Clinical Study of IPI-504 in Advanced Prostate Cancer 7/16/2008
BioAlliance Pharma Suspends Phase II/III Trial of Doxorubicin Transdrug(R) in Primary Liver Cancer 7/16/2008
ADVENTRX Pharmaceuticals Inc. (ANX) Announces Preliminary Response Rate Data From Discontinued Phase 3 Trial of CoFactor(R) 7/1/2008
Novexel Discontinues Development of NXL 101 6/30/2008
Gene-testing Firms Under Fire 6/16/2008
Novo Nordisk A/S (NVO) Discontinues Phase 3 Clinical Trial with NovoSeven(R) in Trauma 6/11/2008
AVI BioPharma, Inc. (AVII) Provides Update on New Business Plan: Discontinues Drug Program, Cuts Jobs 6/10/2008
EXACT Sciences Corporation (EXAS) Reports on Laboratory Corporation of America Holdings (LH)'s Plans to Launch a New Laboratory-developed Stool-based DNA Screening Test for Colorectal Cancer in 2008; LabCorp Stopped Offering PreGen-Plus 6/5/2008
Merck & Co., Inc. (MRK) Ends Study of Cholesterol Drug 5/21/2008
Dynavax Technologies Corporation (DVAX) Ends Development Of Allergy Drug Tolamba After Trial Failure 5/16/2008
Pharmexa A/S (PHARMX.CO) Stops One of Two Phase III Trials 5/13/2008
SGX Pharmaceuticals, Inc. (SGXP) Discontinued Development of SGX523; Announces First Quarter Financial Results 5/13/2008
King Pharmaceuticals®, Inc. Announces Tilade Inhaler to be Discontinued 5/2/2008
NUCRYST Pharmaceuticals Corp. (WEDX) Announces Management Realignment and R&D Portfolio Change; Discontinued Development of NPI 32101 for Inflammatory Bowel Disease (IBD) 5/1/2008
Replidyne, Inc. (RDYN) Discontinues Phase III Trial to Conserve Cash 4/23/2008
Inspire Pharmaceuticals, Inc. (ISPH) to Discontinue Development of Epinastine Nasal Spray 4/23/2008
Synexus' AstraZeneca PLC (AZN)'s Crestor Jupiter Study Stopped Early 4/18/2008
Elan Corporation PLC (ELN), Wyeth (WYE) Suspend Alzheimer's Vaccine Study 4/18/2008
ViroPharma Incorporated (VPHM) and Wyeth Pharmaceuticals End Development of Hepatitis C Drug 4/17/2008
Eisai Company, Ltd. (ESALY.PK) to Drop E2007 Development for Parkinson's Disease 4/11/2008
ArQule, Inc. (ARQL) Provides Clinical Update on E2F-1 Program; Company Plans to Stop Further Clinical Testing 4/10/2008
Pfizer Inc. (PFE) Announces Discontinuation of Phase III Clinical Trial for Patients with Advanced Melanoma 4/2/2008
Takeda Pharmaceutical Co. Ltd. (TKDG.DE) Says to Drop Development of Cholesterol Drug 3/28/2008
Keryx Biopharmaceuticals (KERX) Announces Termination of SUN-MACRO Phase 4 Trial 3/28/2008
Sonus Pharmaceuticals, Inc. (SNUS) Ends Discovery Efforts of Two Programs and Reduces its Headcount 3/25/2008
EPIX Pharmaceuticals, Inc. (EPIX) to Stop Clinical Development of Depression Drug 3/20/2008
Nuvelo, Inc. (NUVO) Announces Phase 2 SONOMA-3 Trial Did Not Meet Target Product Profile and Discontinues Alfimeprase Development 3/18/2008
Genitope Corporation (GTOP) Stops Cancer Vaccine Program, Looking at Finances 3/11/2008
Alkermes (ALKS) Receives Notice from Eli Lilly and Company (LLY) Terminating Inhaled Insulin Program 3/7/2008
Alkermes (ALKS) Provides Update on Inhaled Insulin Program; Eli Lilly and Company (LLY) Expected to Discontinue the Program 3/7/2008
Strativa Pharmaceuticals, a Division of Par Pharmaceutical, Inc., Announces the Discontinuation of the Development Program for Pafuramidine 2/25/2008
Baxter International, Inc. (BAX) Halts Heparin Production Amid Reactions 2/12/2008
Eli Lilly and Company (LLY) Announces Discontinuation of Humatin (Paromomycin Sulfate Capsules, USP) 2/8/2008
Neose Technologies, Inc. (NTEC) Announces Discontinuation of NE-180 Program; Job Cuts 1/30/2008
NMT Medical, Inc (NMTI) Terminates Further Enrollment in MIST II 1/23/2008
Bayer HealthCare Pharmaceuticals (BAY) Establishes US Special Access Program for Leukine(R) While Replacing Current Liquid Formulation 1/23/2008
Unfavorable Drug Studies Don't Get Into Print: Report 1/17/2008
NitroMed, Inc. (NTMD) Reports on BiDil XR(TM) Progress Following FDA Meeting, Announces Restructuring and Suspension of BiDil(R) Sales Force, and Retains Investment Bank to Advise on Strategic Options 1/16/2008
Novacea, Inc. (NOVC) to Discontinue Cancer Drug Trial 1/3/2008



//-->